Roivant and Sinovant Launch Cytovant Sciences in Partnership w...
HONG KONG and MARTINSRIED, Germany and MUNICH, April 4, 2019 /PRNewswire-AsiaNet/ -- -- Cytovant licenses East Asian rights for a research-stage T-cell receptor(TCR) against tumor antigen NY-ESO-1 as well as rights for Medigene'sdendritic cell (DC) vaccine for the treatment of patients across East Asia-- Cy...
Authors: LATEST ASIANET NEWS RELEASES